Perspective Therapeutics (CATX) Tax Provisions (2023)
Perspective Therapeutics' (CATX) quarterly Tax Provisions came in at $10.5 million in Q4 2023, up 200.0% quarter-over-quarter from -$10.5 million in Q1 2023.
Perspective Therapeutics (CATX) Tax Provisions (2023) Analysis & Trends
Perspective Therapeutics has disclosed Tax Provisions across 1 years of filings, most recently posting $10.5 million for Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 372.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 105.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 254.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -176.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 78.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -51.51 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 70.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 94.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 84.20 Mn |
| 10 | Perspective Therapeutics | 308.74 Mn | 308.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 10.50 Mn |
| Mar 31, 2023 | -10.50 Mn |